Heiko Götte

Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (EXPAND): a randomised, open-label phase 3 trial

Florian Lordick, Yoon‐Koo Kang, Hyun Cheol Chung et al. · The Lancet Oncology · 2013 · 830 citations · Full text

Gastrointestinal Oncology, Advanced Gastric Cancer, Open-label Phase 3 +9

HLA association is different in children and adults with severe acquired aplastic anemia

Monika Führer, Jürgen Durner, Günter Brünnler et al. · Pediatric Blood & Cancer · 2006 · 30 citations

Sample size planning for phase II trials based on success probabilities for phase III

Heiko Götte, Armin Schüler, Marietta Kirchner et al. · Pharmaceutical Statistics · 2015 · 29 citations

Field Trial, Rare Event Estimation, Sampling Technique +21

Delayed treatment effects, treatment switching and heterogeneous patient populations: How to design and analyze<scp>RCTs</scp>in oncology

Robin Ristl, Nicolás Ballarini, Heiko Götte et al. · Pharmaceutical Statistics · 2020 · 25 citations · Full text

Utility‐based optimization of phase II/III programs

Marietta Kirchner, Meinhard Kieser, Heiko Götte et al. · Statistics in Medicine · 2015 · 23 citations